Header cover image

Commercial Services Healthcare Sector

Results

2307

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2307 companies

ANI Pharmaceuticals

Market Cap: US$1.2b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

ANIP

US$59.08

7D

-2.1%

1Y

-4.2%

Ocular Therapeutix

Market Cap: US$1.2b

A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.

OCUL

US$7.30

7D

5.3%

1Y

21.7%

U.S. Physical Therapy

Market Cap: US$1.2b

Operates and manages outpatient physical therapy clinics.

USPH

US$77.28

7D

0.04%

1Y

-25.0%

Sienna Senior Living

Market Cap: CA$1.7b

Provides senior living services in Canada.

SIA

CA$17.90

7D

3.1%

1Y

20.3%

CVS Group

Market Cap: UK£892.4m

Engages in veterinary, pet crematoria, online pharmacy, and retail businesses.

CVSG

UK£12.44

7D

-1.6%

1Y

20.1%

Amphastar Pharmaceuticals

Market Cap: US$1.2b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

AMPH

US$24.16

7D

3.7%

1Y

-44.4%

Innoviva

Market Cap: US$1.2b

Engages in the development and commercialization of pharmaceutical products in the United States and internationally.

INVA

US$18.95

7D

5.2%

1Y

17.8%

Pulse Biosciences

Market Cap: US$1.1b

Operates as a novel bioelectric medicine company.

PLSE

US$17.30

7D

6.1%

1Y

44.9%

Natus Medical

Market Cap: US$1.1b

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.

NTUS

US$32.96

7D

0.8%

1Y

34.4%

Viridian Therapeutics

Market Cap: US$1.1b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

VRDN

US$13.66

7D

10.3%

1Y

7.6%

Aveanna Healthcare Holdings

Market Cap: US$1.1b

A diversified home care platform company, provides pediatric and adult healthcare services in the United States.

AVAH

US$5.49

7D

-5.7%

1Y

94.7%

Aurinia Pharmaceuticals

Market Cap: US$1.1b

A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.

AUPH

US$8.34

7D

6.2%

1Y

50.8%

10x Genomics

Market Cap: US$1.1b

A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.

TXG

US$8.32

7D

-8.8%

1Y

-65.4%

Establishment Labs Holdings

Market Cap: US$1.1b

A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.

ESTA

US$35.88

7D

-1.6%

1Y

-32.7%

BioLife Solutions

Market Cap: US$1.1b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

BLFS

US$22.09

7D

0.2%

1Y

1.0%

Spire Healthcare Group

Market Cap: UK£793.5m

Owns and operates private hospitals and clinics in the United Kingdom.

SPI

UK£1.97

7D

-0.7%

1Y

-25.9%

MiMedx Group

Market Cap: US$1.1b

Develops and distributes placental tissue allografts for various sectors of healthcare.

MDXG

US$6.90

7D

-0.9%

1Y

-12.1%

OPKO Health

Market Cap: US$1.1b

A healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.

OPK

US$1.30

7D

3.2%

1Y

-1.5%

Mineralys Therapeutics

Market Cap: US$1.0b

A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.

MLYS

US$16.66

7D

10.3%

1Y

33.1%

Neuren Pharmaceuticals

Market Cap: AU$1.6b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$12.92

7D

-2.0%

1Y

-37.6%

Integra LifeSciences Holdings

Market Cap: US$1.0b

Manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.

IART

US$12.69

7D

-1.8%

1Y

-54.9%

Harrow

Market Cap: US$1.0b

An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.

HROW

US$26.73

7D

6.4%

1Y

55.2%

NeoGenomics

Market Cap: US$1.0b

Operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.

NEO

US$7.40

7D

-7.0%

1Y

-48.8%

agilon health

Market Cap: US$1.0b

Provides healthcare services for seniors through primary care physicians in the communities of the United States.

AGL

US$2.35

7D

-12.0%

1Y

-60.8%

Evolent Health

Market Cap: US$1.0b

Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.

EVH

US$8.00

7D

-10.5%

1Y

-65.6%

Pennant Group

Market Cap: US$1.0b

Provides healthcare services in the United States.

PNTG

US$28.63

7D

-2.3%

1Y

23.8%

Wave Life Sciences

Market Cap: US$1.0b

A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.

WVE

US$6.04

7D

-4.9%

1Y

-6.2%

Gyre Therapeutics

Market Cap: US$1.0b

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

GYRE

US$10.37

7D

-0.2%

1Y

-23.4%

Intellia Therapeutics

Market Cap: US$1.0b

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

NTLA

US$9.20

7D

16.8%

1Y

-64.6%

Craneware

Market Cap: UK£745.9m

Develops, licenses, and supports computer software for the healthcare industry in the United States.

CRW

UK£21.30

7D

8.1%

1Y

-3.6%

Ardelyx

Market Cap: US$1.0b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

ARDX

US$3.99

7D

21.6%

1Y

-49.0%

CareDx

Market Cap: US$987.8m

Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.

CDNA

US$17.05

7D

6.4%

1Y

9.5%

Nutex Health

Market Cap: US$986.3m

Operates as a physician-led, healthcare services, and operations company in the United States.

NUTX

US$169.00

7D

6.4%

1Y

2,214.8%

Phibro Animal Health

Market Cap: US$976.5m

Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.

PAHC

US$23.25

7D

-0.5%

1Y

26.3%

CureVac

Market Cap: US$963.7m

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

CVAC

US$3.90

7D

15.7%

1Y

-0.3%

Collegium Pharmaceutical

Market Cap: US$963.0m

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

COLL

US$29.47

7D

1.4%

1Y

-13.8%

Page 9 of 65